Genetic Therapy, Inc.
Records under this name other than patents Genetic Therapy, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,761,884 | Vectors including foreign genes and negative selective markers Lapsed on the fee record Ended Jul 13, 2012 · From the USPTO record | Lapsed on the fee record | Ended Jul 13, 2012 | From the USPTO record |
| US 6,669,935 | Delivery of therapeutic agents by gene therapy Formerly held Lapsed on the fee record Ended Dec 30, 2011 · From the USPTO record | Lapsed on the fee record | Ended Dec 30, 2011 | From the USPTO record |
| US 6,649,375 | Adenoviral vectors for enhanced gene expression Lapsed on the fee record Ended Nov 18, 2011 · From the USPTO record | Lapsed on the fee record | Ended Nov 18, 2011 | From the USPTO record |
| US 6,638,762 | Tissue-vectors specific replication and gene expression Formerly held Lapsed on the fee record Ended Oct 28, 2011 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2011 | From the USPTO record |
| US 6,551,587 | Vectors for tissue-specific replication Formerly held Lapsed on the fee record Ended Apr 22, 2011 · From the USPTO record | Lapsed on the fee record | Ended Apr 22, 2011 | From the USPTO record |
| US 7,109,029 | Novel Vector Constructs Formerly held Lapsed on the fee record Ended Sep 19, 2010 · High confidence | Lapsed on the fee record | Ended Sep 19, 2010 | High confidence |
| US 6,984,379 | Gene therapy by administration of genetically engineered CD34+ cells obtained from cord blood Formerly held Lapsed on the fee record Ended Jan 10, 2010 · From the USPTO record | Lapsed on the fee record | Ended Jan 10, 2010 | From the USPTO record |
| US 6,156,497 | Recombinase-mediated generation of adenoviral vectors Lapsed on the fee record Ended Dec 5, 2004 · From the USPTO record | Lapsed on the fee record | Ended Dec 5, 2004 | From the USPTO record |
| US 5,543,328 | Adenoviruses having modified fiber proteins Term ended Term ended no later than Aug 6, 2016 · Low confidence | Term ended | Term ended no later than Aug 6, 2016 | Low confidence |
| US 5,563,068 | Bioreactor Formerly held Term ended Term ended no later than Oct 8, 2016 · Low confidence | Term ended | Term ended no later than Oct 8, 2016 | Low confidence |